Vitex agnus-castus (chasteberry)

EMA-monograph herb with RCT evidence for PMS symptoms, though the size of the effect is uncertain.

Evidence
Preliminary evidenceGRADE certainty: Low
Typical dose
Standardised extract: 20–40 mg/day
Time to effect
Symptom reduction emerges over 2–3 menstrual cycles
Safety
Has documented cautions

Evidence ratings summarise published research on Vitex agnus-castus (chasteberry) in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.

Ask about Vitex agnus-castus (chasteberry)

Interactions

Taking any medication?

Check Vitex agnus-castus (chasteberry) against it.

Why

Vitex agnus-castus (chasteberry) holds an EMA HMPC monograph for premenstrual complaints. An RCT and a meta-analysis report improvement in premenstrual symptoms versus placebo, but the pooled trials vary widely, most were at high risk of bias and publication bias is likely, so the true size of the effect is uncertain. The Schellenberg BMJ 2001 trial in 170 women found 52% responders on vitex vs 24% on placebo over 3 cycles.

How it works

Acts on dopamine D2 receptors in the anterior pituitary, reducing prolactin secretion, which may contribute to PMS effects. Does not directly bind oestrogen or progesterone receptors at clinical doses.

Expected onset · Symptom reduction emerges over 2–3 menstrual cycles (8–12 weeks)

How to take

Dosage

Standardised extract: 20–40 mg/day (the Schellenberg trial used extract Ze 440). Some trials use up to 240 mg/day of less concentrated extracts.

Timing

Once daily in the morning

On the label

Standardised extracts with stated milligrams; the Schellenberg trial used Ze 440. Generic chasteberry preparations vary widely.

Studied in

Women with premenstrual syndrome (mood, irritability, breast tenderness, headache).

Safety

Avoid in pregnancy and breastfeeding (may reduce milk supply via prolactin suppression). Theoretical antagonism with hormonal contraceptives and IVF. Coordinate with the prescribing clinician. Possible additive effect with dopaminergic and antidopaminergic medications. Mild GI side effects, headache, rash possible.
Loading interactions…

Evidence

At a glance

Schellenberg 2001 BMJ RCT (n=170 women with premenstrual syndrome): agnus castus fruit extract for three cycles improved symptoms more than placebo, with responder rates of 52% versus 24%. Verkaik 2017 Am J Obstet Gynecol meta-analysis found a large pooled effect but very high heterogeneity, high risk of bias and likely publication bias. The EMA lists well-established use for premenstrual symptoms.

GRADE certainty: Low — rated by Healicus using the GRADE method

Questions people ask

Does Vitex agnus-castus (chasteberry) work?

Schellenberg 2001 BMJ RCT (n=170 women with premenstrual syndrome): agnus castus fruit extract for three cycles improved symptoms more than placebo, with responder rates of 52% versus 24%. Verkaik 2017 Am J Obstet Gynecol meta-analysis found a large pooled effect but very high heterogeneity, high risk of bias and likely publication bias. The EMA lists well-established use for premenstrual symptoms. Certainty of the evidence: Low, rated by Healicus using the GRADE method.

How is Vitex agnus-castus (chasteberry) taken?

Standardised extract: 20–40 mg/day (the Schellenberg trial used extract Ze 440). Some trials use up to 240 mg/day of less concentrated extracts. Timing: Once daily in the morning. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.

Are there interactions or cautions?

Avoid in pregnancy and breastfeeding (may reduce milk supply via prolactin suppression). Theoretical antagonism with hormonal contraceptives and IVF. Coordinate with the prescribing clinician. Possible additive effect with dopaminergic and antidopaminergic medications. Mild GI side effects, headache, rash possible. Documented drug and supplement interactions can be looked up in the free interaction reference.

What is the evidence based on?

Sources: EMA HMPC monograph, Vitex agnus-castus L., fructus (Well-Established Use + Traditional Use); Schellenberg et al., BMJ 2001, Vitex agnus-castus extract for premenstrual syndrome (RCT, n=170); Verkaik et al., Am J Obstet Gynecol 2017, Vitex agnus-castus for premenstrual syndrome: systematic review and meta-analysis.

One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.